ArticleOncotarget2017
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.
Esperanza Martín-Sánchez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it
ArticleOncotarget2017
Esperanza Martín-Sánchez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.